F
FeetMe
Proposing a medical device connected to pressure sensors soles
About FeetMe
FeetMe, established in Paris in 2013, operates at the intersection of medical devices and digital health, focusing on mobility disorders. The company was founded by Alexis Mathieu who, after studying at École Polytechnique and UC Berkeley, aimed to address unmet clinical needs within the rehabilitation community. Since its inception, the company has secured $12.7 million in funding over four rounds, including a significant $10.4 million Series A round in September 2019 led by LBO France.
Read full description
The core of FeetMe's business is a platform for real-world disease diagnostics, monitoring, and rehabilitation centered on movement data. The company's main offering is the FeetMe Monitor, a system of medical-grade connected insoles designed for gait and posture analysis in real-life conditions. These insoles are equipped with a suite of sensors, including 18 pressure sensors and 6-axis motion sensors, which collect precise data on a patient's functional capacity. This data is then processed by proprietary algorithms to provide over 20 metrics for every step, such as stride time, cadence, and pressure distribution. The system is designed for seamless integration into a patient's daily life, featuring wireless charging and Bluetooth connectivity.
FeetMe's business model targets healthcare providers, including hospitals and rehabilitation clinics, as well as the pharmaceutical industry for clinical trials. The collected data enables clinicians to remotely monitor patients, track disease progression for conditions like Parkinson's disease, multiple sclerosis, and diabetic foot problems, and tailor rehabilitation programs. For pharmaceutical clients, the technology offers a method to gather real-world evidence and high-precision measurements, potentially accelerating clinical research. The product ecosystem includes the smart insoles, a mobile application for real-time biofeedback and data collection, and a web-based dashboard for in-depth analysis and reporting by healthcare professionals.
At a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Paris, France
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 61.3/100
- Industry
- Health
- Sub-industry
- Medical Devices, Health Platform
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Analytics, Remote Monitoring
- Technology
- Hardware, Deep Tech, Connected Device, Recognition Technology, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLEOther financing | Mar 2022 | $0 | — | SOSV | — |
| SERIES AOther financing | Sep 2019 | $10M | $41M | Partech · Eurazeo · SOSV · LBO France | ↗ |
Growth signals
Latest recorded traffic for FeetMe is 0 monthly website visits, down 100% over the last three months. FeetMe's team declined 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A5 investors entered at this stage
Other known investors6 additional known investors
EIT Health
École Polytechnique - IP Paris
IP Paris
Agoranov
Amine MAROUF
Paris Saclay Seed Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about FeetMe on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FeetMe’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.













